Alan Glicklich
CIK: 0001823197
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CalciMedica, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 1, 2026CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
20K shares- - Aug 19, 2026CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Oct 13, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
937 shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
15K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
10K shares- - Jun 24, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
4.2K shares- - Jan 15, 2025CALC
CalciMedica, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
20K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Aug 19, 2026 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Oct 13, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 937 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 10,000 | - | - | Direct |
| Jun 24, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 4,166 | - | - | Direct |
| Jan 15, 2025 | CALC CalciMedica, Inc. | Award(A) Director Stock Option (Right to Buy) | 20,000 | - | - | Direct |
1-8 of 8 transactions
About Glicklich Alan
Glicklich Alan (SEC CIK 0001823197) files insider reports with the SEC as Director of CalciMedica, Inc. (CALC).
Signal8 holds 6 ownership filings by Glicklich Alan (1 Form 3, 5 Form 4), filed between Jan 16, 2025 and Oct 5, 2026. Those filings report 8 transactions, from Jan 15, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Glicklich Alan's filings is in LA JOLLA, CA.
Recent filings by Glicklich Alan
- Oct 1, 2026: Grant or award of CALC derivative securities (Form 4, code A).
- Aug 19, 2026: Grant or award of CALC derivative securities (Form 4, code A).
- Oct 13, 2025: Grant or award of CALC derivative securities (Form 4, code A).
- Jun 24, 2025: Grants or awards of CALC derivative securities (4 lines, Form 4, code A).
- Jan 15, 2025: Grant or award of CALC derivative securities (Form 4, code A).
Other insiders filing for CalciMedica, Inc. (CALC)
- Zaytsev Evgeny, Director
- Guerard Frederic, Director
- Shaw Allan, Director
- WILSON ROBERT N, Director
- Hebbar Sudarshan, Chief Medical Officer
- Stauderman Kenneth A., Chief Scientific Officer